GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 421 filers reported holding GUARDANT HEALTH INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,659,516 | -10.4% | 1,101,873 | +8.2% | 0.09% | -3.3% |
Q2 2023 | $36,446,118 | +97.7% | 1,018,048 | +29.4% | 0.09% | +71.7% |
Q1 2023 | $18,434,552 | +39.0% | 786,457 | +61.4% | 0.05% | +26.2% |
Q4 2022 | $13,257,824 | +37.1% | 487,420 | +171.4% | 0.04% | +27.3% |
Q3 2022 | $9,668,000 | +3.4% | 179,599 | -22.5% | 0.03% | +6.5% |
Q2 2022 | $9,351,000 | +1068.9% | 231,816 | +2797.7% | 0.03% | +1450.0% |
Q4 2021 | $800,000 | -44.4% | 8,000 | -30.4% | 0.00% | -50.0% |
Q3 2021 | $1,438,000 | -92.2% | 11,500 | -92.3% | 0.00% | -90.5% |
Q2 2021 | $18,552,000 | +0.5% | 149,381 | +23.5% | 0.04% | -12.5% |
Q1 2021 | $18,464,000 | +5101.1% | 120,956 | +4288.8% | 0.05% | +4700.0% |
Q4 2020 | $355,000 | -84.1% | 2,756 | -91.4% | 0.00% | -94.7% |
Q1 2020 | $2,227,000 | +239.5% | 32,000 | +281.0% | 0.02% | +850.0% |
Q4 2019 | $656,000 | -78.7% | 8,400 | -82.6% | 0.00% | -80.0% |
Q3 2019 | $3,084,000 | +1389.9% | 48,332 | +1913.8% | 0.01% | +900.0% |
Q2 2019 | $207,000 | – | 2,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |